Aidar
1 known investors
Aidar develops digital medicine and precision medicine solutions that connect patients, clinicians, and healthcare systems to improve health outcomes. The company serves providers, life sciences companies, and payers with tools for treatment optimization, clinical trial support, and population health management.
Investors · 1
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase IISTTR | 2023 | $1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $276.1K |
| National Science Foundation | Phase I | 2020 | $256K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
- Aidar Health snares TEDCO grant, works toward next step » The Business Monthlybizmonthly.com · 2023
- Aidar Health's Rapid Patient Triage System Gains Federal Funding From BARDAglobalbiodefense.com · 2021
- Aidar Health got FDA clearance for its MouthLab device. Now it wants to grow in Baltimoretechnical.ly · 2021
- Baltimore health tech firm Aidar Health plans funding round, hiring surge after winning FDA clearance - Baltimore Business Journalbizjournals.com · 2021